Vas Narasimhan
News/ News/ Sales and Marketing
CMO John Tsai exits, as Novartis starts revamp that aims to save $1bn
Phil Taylor
Novartis, Oncology, pharma, R&D, senior management, Vas Narasimhan
0 Comment
X
CMO John Tsai exits, as Novartis starts revamp that aims to save $1bn
https://pharmaphorum.com/news/cmo-john-tsai-exits-as-novartis-starts-revamp-that-aims-to-save-1bn/
X
Novartis spent $15bn on M&A last year, with more to come
https://pharmaphorum.com/news/novartis-spent-15bn-on-ma-last-year-with-more-to-come/
Jimenez to step down as Novartis chief, Narasimhan takes over
Andrew McConaghie
Kymriah, Novartis, Vas Narasimhan
0 Comment
X
Jimenez to step down as Novartis chief, Narasimhan takes over
https://pharmaphorum.com/news/jimenez-step-novartis-chief-narasimhan-takes/
AI helping us make smarter, faster decisions, says Novartis R&D chief
Andrew McConaghie
artificial intelligence, NIBR, Novartis, R&D productivity, Vas Narasimhan
0 Comment
X
AI helping us make smarter, faster decisions, says Novartis R&D chief
https://pharmaphorum.com/news/ai-helping-us-says-novartis-rd-chief/